Trends are born, they grow, mature, reach old age and die. The marijuana-legalization trend is only in its infancy. Just as the sale of alcohol began in fits and starts across different states, legal pot’s surge will not be a straight line. It, too, will meet curves in the road, but its trajectory ultimately calls for explosive and sustained growth.
All the data support continued momentum, especially for medical and also recreational marijuana, with growth areas that are now clearly defined. For example, recreational pot products are becoming more diversified, offering transdermal (patches), oil-based, food and beverage alternatives to using marijuana for different market segments that are less intrusive and more socially preferred than smoking weed. This will open up sizeable markets with enormous market-cap potential.
And on medical fronts, with millions of Americans now relying on medical marijuana for their treatment, and hard science, respectable science, now honing in on cannabis’ medical benefits, we forecast explosive growth in this sector, too.
Finally, while Big Pharma’s role will ultimately be shaped by how much regulation and legal enforcement the federal government will exert on both medical and recreational marijuana, the immediate future will see the natural-health and healing industry aggressively engage the legalized, entrepreneur-driven cannabis industry. The range of marijuana products being generated now will find broad audiences among organic and natural health retailers and consumers.
Finally, while Big Pharma’s role will ultimately be shaped by how much regulation and legal enforcement the federal government will exert on both medical and recreational marijuana, the immediate future will see the natural-health and healing industry aggressively engage the legalized, entrepreneur-driven cannabis industry. The range of marijuana products being generated now will find broad audiences among organic and natural health retailers and consumers.